-
公开(公告)号:EP0480455A1
公开(公告)日:1992-04-15
申请号:EP91117375.5
申请日:1991-10-11
IPC分类号: C07D495/04 , A61K31/55
CPC分类号: C07D495/14
摘要: Stable crystals of an acid addition salt of an optically active thienotriazolodiazepine compound or its hydrate of the formula
wherein R 1 is hydrogen, R 2 is 2-phenylethyl substituted by alkyl having 1 to 5 carbon atoms, 2-morpholinocar- bonylethyl or alkyl having 6 to 12 carbon atoms, or R 1 and R 2 may combinedly form a saturated 5-membered ring having one substituent selected from the group consisting of morpholinomethyl, morpholinocarbonyl and N,N-dipropylcarbamoyl, R 3 is halogen, alkyl having 1 to 5 carbon atoms or alkoxy having 1 to 5 carbon atoms, R 4 is trifluoromethyl or alkyl having 1 to 5 carbon atoms, R 5 is hydrogen or methyl, m is 1-2, and n is 0-2. The present invention provides optically active thienotriazolodiazepine compounds having strong PAF-antagonistic activity as markedly stable crystals which are excellent in crystalline property, permit purification by recrystallization, and have high chemical purity and optical purity, thereby rendering industrial large-scale synthesis attainable. In addition, crystallization thereof facilitates medicinal standardization and pharmaceutical formulation.摘要翻译: 光学活性噻吩并三唑并二氮杂化合物或其水合物的酸加成盐的稳定晶体,其中R1是氢,R2是被具有1-5个碳原子的烷基取代的2-苯基乙基,2-吗啉代乙基乙基或具有6-12个碳原子的烷基 碳原子,或者R1和R2可以结合形成具有一个选自吗啉代甲基,吗啉代羰基和N,N-二丙基氨基甲酰基的取代基的饱和五元环,R3是卤素,具有1至5个碳原子的烷基或具有1个 至5个碳原子,R4是三氟甲基或具有1至5个碳原子的烷基,R5是氢或甲基,m是1-2,并且n是0-2。 本发明提供具有强PAF-拮抗活性的光学活性噻吩并三唑并二氮杂化合物作为结晶性优异,允许通过重结晶纯化,并具有高化学纯度和光学纯度的显着稳定的晶体,从而可实现工业大规模合成。 此外,其结晶促进了药物标准化和药物制剂。
-
公开(公告)号:EP0480455B1
公开(公告)日:1997-01-22
申请号:EP91117375.5
申请日:1991-10-11
IPC分类号: C07D495/04 , A61K31/55
CPC分类号: C07D495/14
-